Skip to content

AARD AARD EPS (Diluted)

EPS (Diluted) at other companies

AbbVie logo
AbbVieABBV
$0.39-45.8%
Relmada Therapeutics, Inc. logo
Relmada Therapeutics, Inc.RLMD
-$0.22+62.1%
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
-$0.83-2.5%
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
-$0.07+70.8%
Viking Therapeutics logo
Viking TherapeuticsVKTX
-$1.37-234%
Arvinas logo
ArvinasARVN
-$0.90-179%

Other financials

Income statement

See full
Revenue-
Operating income-$22.5M-115%
Net income-$21.6M-132%

Balance sheet

See full
Cash & equivalents$62.4M+136%
Total debt$336.0K-53.7%
Total equity$87.0M-42.3%
Total assets$98.6M-37.2%

Cash flow

See full
Operating cash flow-$18.9M-65.7%
CapEx--100%
Free cash flow-$16.8M-117%

Valuation

See full
Market cap$124.35M-58.6%
Enterprise value$62.25M-77.4%

Returns & leverage

See full
Return on equity-58.8%
Debt / equity0.0×
Current ratio8.1×-17.8×

Where this comes from

Reported directly by AARD in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: AARD’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about AARD's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AARD's EPS (diluted)?
AARD (AARD) reported EPS (diluted) of -$0.99 in Q1 2026.
How has AARD's EPS (diluted) changed year-over-year?
AARD's EPS (diluted) decreased by 39.4% year-over-year, from -$0.71 to -$0.99.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.